Nuvectis reports phase 1b data for glioma drug candidate NXP200

XTEND reports Q3 revenue of $24.5-26.5 million, names new U.S. CEO

Investing.com · News 7m ago

Propanc reports preclinical data on pancreatic cancer treatment

Investing.com · News 7m ago

Critical Metals receives court approval for European Lithium deal

Investing.com · News 7m ago

HeartBeam gains FDA acceptance into device acceleration program

Investing.com · News 7m ago

Roze AI subsidiary receives patent notice for evacuation system

Investing.com · News 7m ago

Audi marks 10 years of OLED lighting in production vehicles

Investing.com · News 8m ago

Digimarc reports interest in gift card fraud solution at trade show

Investing.com · News 8m ago

Jio Platforms IPO single-lot profit calculator: What will the listing gains be if you get an allotment? Latest GMP today

LiveMint · Markets 16m ago

K&F Growth Acquisition Corp. II converts Class B shares to Class A shares

Investing.com · News 19m ago

Auto & Transport Roundup: Market Talk

Dow Jones · Markets 20m ago